Growth Metrics

Axogen (AXGN) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Axogen 2.00 Bn 1.90 Bn 46.19 Mn -1,292.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,292.23%
Dec 31, 2025 597.17%
Sep 30, 2025 24.98%
Jun 30, 2025 -463.42%
Mar 31, 2025 141.19%
Dec 31, 2024 -193.50%
Sep 30, 2024 -183.42%
Jun 30, 2024 -108.61%
Mar 31, 2024 -313.61%
Dec 31, 2023 77.09%
Sep 30, 2023 101.75%
Jun 30, 2023 528.43%
Mar 31, 2023 89.15%
Dec 31, 2022 91.10%
Sep 30, 2022 143.84%
Jun 30, 2022 154.82%
Mar 31, 2022 -932.30%
Dec 31, 2021 29.80%
Sep 30, 2021 67.93%
Jun 30, 2021 -127.77%
Mar 31, 2021 -89.82%
Dec 31, 2020 -242.44%
Sep 30, 2020 -2,394.25%
Jun 30, 2020 199.74%
Mar 31, 2020 10.04%
Dec 31, 2019 59.01%
Sep 30, 2019 100.87%
Jun 30, 2019 1,309.20%
Mar 31, 2019 1,650.90%
Dec 31, 2018 1,834.42%
Sep 30, 2018 -37,805.21%
Jun 30, 2018 -22.58%
Mar 31, 2018 -173.34%
Dec 31, 2017 -27.44%
Sep 30, 2017 -29.12%
Jun 30, 2017 -411.19%
Mar 31, 2017 62.47%
Dec 31, 2016 -250.63%
Sep 30, 2016 16.43%
Jun 30, 2016 55.54%
Mar 31, 2016 -1,173.75%
Dec 31, 2015 47.93%
Sep 30, 2015 -277.41%
Jun 30, 2015 -34.81%
Mar 31, 2015 81.19%
Dec 31, 2014 -66.52%
Sep 30, 2014 -111.24%
Jun 30, 2014 -307.94%
Mar 31, 2014 -254.96%
Dec 31, 2013 -1,581.51%
Sep 30, 2013 17.96%
Jun 30, 2013 -180.26%
Mar 31, 2013 18.61%
Dec 31, 2012 79.09%
Sep 30, 2012 -100.55%
Jun 30, 2012 -27.06%
Mar 31, 2012 -292.35%
Dec 31, 2011 -145.13%
Sep 30, 2011 14,962.59%